North America AI-assisted Medical Imaging Market
Description
Report Scope
Dual lens approach: top down reconciliation to NA totals and country splits; bottom up attach rate engine by modality with factory vs retrofit mixes, ASP bands, and NA specific evidence weights (FDA/Health Canada cadence, reimbursement signals, enterprise buying, and RWE).
Report Snapshot
- Countries: United States, Canada
- Modalities: CT, MRI, X ray/DR, Ultrasound, PET/Nuclear
- Clinical Areas: Oncology, Neurology/Stroke, Cardiology, Respiratory/Lung, MSK/Ortho, General
- Applications: Triage → detection → reconstruction → integration
- Revenue Streams: Hardware, Software, Services, Cloud/Pay per Use
- End use: Hospitals/IDNs, Imaging Centers, Clinics, Teleradiology, Other. (Section 2, Objective & Scope.)
Dual lens approach: top down reconciliation to NA totals and country splits; bottom up attach rate engine by modality with factory vs retrofit mixes, ASP bands, and NA specific evidence weights (FDA/Health Canada cadence, reimbursement signals, enterprise buying, and RWE).
Report Snapshot
- Trajectory: North America expands to ~US$13.2B by 2032 (~30% CAGR). (Executive Summary, p.10; Table 1, p.14.)
- Attach rate headroom: OEM AI ships on ~20% of new CT and ~15% of new MR—ample runway across ultrasound and PET. (Attach rate discussion & Figure 3, pp.18–19.)
- Reimbursement pull: The U.S. continues to dominate—about 9-to-1 versus Canada—thanks to CMS NTAP renewals (stroke AI) and the emerging CPT stack for CT-FFR, echo strain and breast-AI.
- Enterprise buying power: Large U.S. IDNs lock multi-year “AI-store” licenses, scaling spend faster than underlying scan growth.
- Regulatory clarity: FDA’s Predetermined Change-Control Plan draft allows algorithm upgrades without re-filing, shortening refresh cycles and feeding ARR.
- Canada’s catch-up: Single-payer provinces move more cautiously, but national lung-cancer screening pilots and CADTH’s positive HTA for TB AI push adoption. The lower 29 % CAGR still doubles market size every three years.
- Cross-border vendors: U.S. cloud-AI providers increasingly win Canadian tenders once privacy compliance (PIPEDA/HIPAA) is proven, further narrowing the gap.
- Where to play / how to win: NA GTM Growth & Maturity Matrix, competitive dataset, regulatory velocity, and M&A watchlist. (Figures & tables, pp.15–18.)
- Country playbooks: U.S. & Canada GTM radars, channel/pricing matrices, customer tier potential, and timelines with 12 month action cues. (U.S. pp.31–38; Canada pp.52–54.)
- Forecast depth: Breakouts by country, modality, clinical area, application, revenue stream, and end use through 2032. (Tables across pp.24–30, 43–51.)
Table of Contents
54 Pages
- Section 1 – Executive Summary
- 25 Second Read
- Size & Trajectory
- Modality & Attach Rate Dynamics
- Buyer & Route To Market
- Competitive Temperature
- What To Do In The Next 12 Months
- Section 2 – Research Methodology
- Objective & Scope
- Dual Lens Architecture
- North America–specific Evidence Stack & Weights
- Calibration Choices (Na)
- Section 3 - North American Market
- Market Summary
- Market Size & Drivers
- Latest Trends
- Strategic Outlook
- Competitive Environment
- New Focus Areas
- North American Market Estimates & Forecasts (2023-2032)
- Ai Imaging Market By Country - North America
- What’s Driving The Numbers
- Implications
- Markintel Gtm Growth And Maturity Matrix – North America
- Competitive Dataset – North America
- Competitive Context — North America Ai-imaging 2024
- Strategic Takeaways
- Growth & Maturity Highlights – North America
- M&A Watchlist — North America Rising Stars
- Regulatory Velocity – North America
- Oem Ai Attach-rate By Modality
- Attach Rate Trends – North America
- Factory Vs Retrofit – North America
- Section 4 - United States Market
- Market Summary – United States
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
- Market Overview – United States
- Demographics & Epidemiology
- Macro Economics & Health Spending
- Imaging Volume & Installed Base
- Regulatory & Reimbursement Snapshot
- Healthcare Delivery & Practice Patterns
- Ai Market Dynamics (Imaging)
- Competitive Landscape
- Takeaways For Vendors
- Us Market By Clinical Area
- Forecast By Clinical Area (2023-2032, Usd Mill)
- U.S. Ai-imaging Outlook By Clinical Area (2023 → 2032)
- Key Dynamics To Watch
- Implications For Vendors
- Us Market By Imaging Modality
- Forecast By Modality (2023-2032, Usd Mill)
- U.S. Modality Outlook: Who Grows, Who Overtakes
- Key Takeaways
- Us Market By Revenue Stream
- Forecast By Revenue Stream (2023-2032, Usd Mill)
- U.S. Revenue Stream Shift: From Capital Boxes To Recurring Bytes
- What’s Driving The Mix Change
- Implications For Vendors
- Us Market By Clinical Application
- Forecast By Clinical Application (2023-2032, Usd Mill)
- Outlook By Clinical Application
- Highlights
- Implications
- Us Market By End-use Organization
- Forecast By End-use Organization (2023-2032, Usd Mill)
- Who Buys Ai—and How That Mix Shifts Through 2032
- What’s Behind The Shift
- Strategic Implications For Vendors
- Us Market By Ai Technology
- Forecast By Ai Technology (2023-2032, Usd Mill)
- Outlook By Core Technology (2023-2032)
- Markintel Growth Maturity Matrix – Us & Canada
- Competitive Dataset – United States
- Competitive Context — U.S./North America
- What To Watch Next
- Markintel Solution Adoption & Growth Matrix – Us & Canada
- Scorecard — Solution Adoption & Growth Matrix (U.S. & Canada)
- Strategic Implications For Stakeholders
- Markintel Ecosystem Collaboration Matrix – Us & Canada
- Who To Partner With And How Deep?
- What Succeess Looks Like In Each Quadrant
- Stratregic Guidance
- Gtm At A Glance – United States
- Channel & Pricing Matrix
- Gtm Readiness Radar - Us
- Customer Tier Potential - Us
- Gtm Timeline (2025–2028) - Us
- Fast Strategic Cues (2025)
- Regulatory X Funding Heatmap – Us
- Adjacency-opportunity Radar – Us
- Whitespace Partner-fit Matrix – Us
- Section 5 - Canadian Market
- Market Summary: Canada
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
- Market Overview - Canada
- Demographics & Epidemiology
- Imaging Supply & Utilization
- Health System & Practice Patterns
- Regulatory & Reimbursement
- Ai-imaging Market Dynamics
- Competitive Snapshot
- Key Implications
- Canadian Market By Clinical Area
- Forecast By Clinical Area (2023-2032, Usd Mill)
- Outlook By Clinical Area
- Key Dynamics To Watch
- Implications For Vendors
- Canadian Market By Imaging Modality
- Forecast By Imaging Modality (2023-2032, Usd Mill)
- Outlook By Modality
- Key Dynamics To Watch (2025-27)
- Implications For Vendors
- Canadian Market By Revenue Stream
- Forecast By Revenue Stream (2023-2032, Usd Mill)
- What’s Driving Each Revenue Stream
- Key Dynamics To Watch
- Implications For Vendors
- Canadian Market By Clinical Application
- Forecast By Clinical Application (2023-2032, Usd Mill)
- Outlook & Drivers By Application
- Key Market Dynamics To 2027
- Implications For Vendors And Providers
- Canadian Market By End-use Organization
- Forecast By End-use Organization (2023-2032, Usd Mill)
- Outlook 2025-2032
- Key Drivers By Segment
- Implications For Vendors
- Strategic Takeaways
- Canadian Market By Ai Technology
- Forecast By Ai Technology (2023-2032, Usd Mill)
- Highlights By Technology
- Key Dynamics To Watch (2025 27)
- Implications For Vendors & Providers
- Gtm At A Glance - Canada
- Gtm Readiness Radar - Canada
- Tiered Customer Landscape
- Channel & Pricing Matrix
- Gtm Timeline (Canada)
- Fast Cues For 2025 Stakeholders
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
